BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Circular RNA hsa_circ_0075828 promotes bladder cancer cell proliferation through activation of CREB1

  • Zhuang, Chengle (Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen-Peking University-the Hong Kong University of Science and Technology Medical Center) ;
  • Huang, Xinbo (Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen-Peking University-the Hong Kong University of Science and Technology Medical Center) ;
  • Yu, Jing (Department of Laboratory Medicine, Peking University Shenzhen Hospital) ;
  • Gui, Yaoting (Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen-Peking University-the Hong Kong University of Science and Technology Medical Center)
  • Received : 2019.02.25
  • Accepted : 2019.05.03
  • Published : 2020.02.29
Download PDF
⟨ Previous Next ⟩

Abstract

Circular RNAs (circRNAs), one kind of non-coding RNA, have been reported as critical regulators for modulating gene expression in cancer. In this study, microarray analysis was used to screen circRNA expression profiles of bladder cancer (BC) 5637 cells, T24 cells and normal control SV-HUC-1 cells. The data from the microarray showed that hsa_circ_0075828 (named circCASC15) was most highly expressed in 5637 and T24 cells. circCASC15 was highly expressed in BC tissues and cells. Overexpression of circCASC15 was closely associated with BC tumor stage and promoted cell proliferation significantly in vitro and in vivo. Mechanistically, circCASC15 could act as miR-1224-5p sponge to activate the expression of CREB1 to promote cell proliferation in BC. In short, circCASC15 promotes cell proliferation in BC, which might be a new molecular target for BC diagnosis and therapy.

Keywords

References

  1. Siegel RL, Miller KD and Jemal A (2017) Cancer Statistics, 2017. CA Cancer J Clin 67, 7-30 https://doi.org/10.3322/caac.21387
  2. Cote RJ, Dunn MD, Chatterjee SJ et al (1998) Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res 58, 1090-1094
  3. Cambier S, Sylvester RJ, Collette L et al (2016) EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin. Eur Urol 69, 60-69 https://doi.org/10.1016/j.eururo.2015.06.045
  4. Wu X, Liu D, Tao D et al (2016) BRD4 Regulates EZH2 Transcription through Upregulation of C-MYC and Represents a Novel Therapeutic Target in Bladder Cancer. Mol Cancer Ther 15, 1029-1042 https://doi.org/10.1158/1535-7163.MCT-15-0750
  5. Wilusz JE and Sharp PA (2013) Molecular biology. A circuitous route to noncoding RNA. Science 340, 440-441 https://doi.org/10.1126/science.1238522
  6. Salzman J, Chen RE, Olsen MN, Wang PL and Brown PO (2013) Cell-type specific features of circular RNA expression. PLoS Genet 9, e1003777 https://doi.org/10.1371/journal.pgen.1003777
  7. Zhao ZJ and Shen J (2017) Circular RNA participates in the carcinogenesis and the malignant behavior of cancer. RNA Biol 14, 514-521 https://doi.org/10.1080/15476286.2015.1122162
  8. Hansen TB, Jensen TI, Clausen BH et al (2013) Natural RNA circles function as efficient microRNA sponges. Nature 495, 384-388 https://doi.org/10.1038/nature11993
  9. Liu H, Liu Y, Bian Z et al (2018) Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 (Kip1) axis. Mol Cancer 17, 151 https://doi.org/10.1186/s12943-018-0902-1
  10. Bai N, Peng E, Qiu X et al (2018) circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346. J Exp Clin Cancer Res 37, 172 https://doi.org/10.1186/s13046-018-0838-8
  11. Su H, Tao T, Yang Z et al (2019) Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression. Mol Cancer 18, 27 https://doi.org/10.1186/s12943-019-0951-0
  12. Chen X, Chen RX, Wei WS et al (2018) PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial-Mesenchymal Transition. Clin Cancer Res 24, 6319-6330 https://doi.org/10.1158/1078-0432.CCR-18-1270
  13. Li Y, Zheng F, Xiao X et al (2017) CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Rep 18, 1646-1659 https://doi.org/10.15252/embr.201643581
  14. Bolha L, Ravnik-Glavac M and Glavac D (2017) Circular RNAs: Biogenesis, Function, and a Role as Possible Cancer Biomarkers. Int J Genomics 2017, 6218353
  15. Lewis BP, Burge CB and Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 https://doi.org/10.1016/j.cell.2004.12.035
  16. Zhong Z, Huang M, Lv M et al (2017) Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway. Cancer Lett 403, 305-317 https://doi.org/10.1016/j.canlet.2017.06.027
  17. Agarwal V, Bell GW, Nam JW and Bartel DP (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife 4, e05005 https://doi.org/10.7554/eLife.05005
  18. Xu Z, Yan Y, Zeng S et al (2018) Circular RNAs: clinical relevance in cancer. Oncotarget 9, 1444-1460 https://doi.org/10.18632/oncotarget.22846
  19. Yang C, Yuan W, Yang X et al (2018) Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression. Mol Cancer 17, 19 https://doi.org/10.1186/s12943-018-0771-7
  20. Wu Z, Huang W, Wang X et al (2018) Circular RNA CEP128 acts as a sponge of miR-145-5p in promoting the bladder cancer progression via regulating SOX11. Mol Med 24, 40
  21. Yang X, Yuan W, Tao J et al (2017) Identification of circular RNA signature in bladder cancer. J Cancer 8, 3456-3463 https://doi.org/10.7150/jca.19345
  22. Imani S, Wu RC and Fu J (2018) MicroRNA-34 family in breast cancer: from research to therapeutic potential. J Cancer 9, 3765-3775 https://doi.org/10.7150/jca.25576
  23. Gu L, Lu LS, Zhou DL and Liu ZC (2018) UCA1 promotes cell proliferation and invasion of gastric cancer by targeting CREB1 sponging to miR-590-3p. Cancer Med 7, 1253-1263 https://doi.org/10.1002/cam4.1310
  24. Sunkel B, Wu D, Chen Z et al (2017) Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence. Nucleic Acids Res 45, 6993 https://doi.org/10.1093/nar/gkx282
  25. Pan J, Li X, Wu W et al (2016) Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells. Cancer Lett 382, 64-76 https://doi.org/10.1016/j.canlet.2016.08.015
  26. Xu X, Zhu Y, Liang Z et al (2016) c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3beta/Snail signaling. Cell Death Dis 7, e2088 https://doi.org/10.1038/cddis.2015.274
  27. Yang C, Li X, Wang Y, Zhao L and Chen W (2012) Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene 496, 8-16 https://doi.org/10.1016/j.gene.2012.01.012